Ourania Tatsis

CIK 1789815 · EVP, Chief Reg. & Quality Off. · last filed 2026-05-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$20.92M

Companies

3

Total Filings

52

Lifetime Open-Market Net

-$20.57M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ODTX Director $0 1 2026-05-11
VRTX EVP, Chief Reg. & Quality Off. 47,023 $444.93 $20.92M -$20.57M 48 2026-02-26
Verve Therapeutics, Inc. (VERV) Delisted Director $11.13 $0 3 2025-07-28

Recent Filings · Page 3 of 6

52 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-06-03 VRTX Sell (S) −4,600 -$2.03M EDGAR
2024-02-27 VRTX Mixed −3,663 -$1.58M EDGAR
2024-02-23 VRTX Sell (S) −360 -$151.8K EDGAR
2024-02-21 VRTX Mixed −8,352 -$3.53M EDGAR
2024-02-13 VRTX Mixed −2,414 -$1.02M EDGAR
2024-02-08 VRTX Grant (A) +21,956 $0 EDGAR
2023-08-25 VRTX Sell (S) −2,500 -$887.5K EDGAR
2023-08-14 VRTX Sell (S) −5,750 -$1.99M EDGAR
2023-02-28 VRTX Mixed −3,662 -$1.06M EDGAR
2023-02-22 VRTX Mixed −4,978 -$1.46M EDGAR
Showing 2130 of 52
Page 3 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.